Resolutions of the Annual General Meeting of Shareholders from 20 June 2025
The annual general meeting of shareholders of AS Trigon Property Development (registry code: 10106774; hereinafter the 'Company') was held on 20 June 2025 in Tallinn, Pärnu mnt 18.
The annual general meeting started at 10:00. 2,570,164 votes represented by the shares of the Company, i.e. 57,127% of all the votes represented by the shares of the Company, participated at the meeting. Therefore, the annual general meeting was competent to pass resolutions regarding the items on the agenda.
Resolutions of the annual general meeting:
1. Approval of the annual report of the Company for the financial year 2024
To approve the annual report of the Company for the financial year 2024, in accordance with which the balance sheet value of the Company as at 31 December 2024 was 1,873,680 euros and the net profit for the financial year was 167,409 euros.
In favour 2,569,152 votes i.e. 99.96% of all votes in the meeting and against 1,012 votes i.e. 0,04% of all votes in the meeting. Thus the resolution was adopted.
2. Allocation of the net profit for the financial year 2024
To approve the net profit allocation proposal made by the Management Board and to carry the net profit for 2024 in the amount of 167,409 euros to accumulated profit.
In favour 2,569,152 votes i.e. 99.96% of all votes in the meeting and against 1,012 votes i.e. 0,04% of all votes in the meeting. Thus the resolution was adopted.
3. Appointment of the auditor for the financial year 2025 and determining the remuneration policy for the auditor
To appoint AS PricewaterhouseCoopers (registry code 10142876, address Pärnu mnt 15, 10141 Tallinn) as the auditor of the Company for the financial year 2025. The auditing services will be paid for in accordance with the contract to be drawn up with the auditor.
In favour 2,569,152 votes i.e. 99.96% of all votes in the meeting and against 1,012 votes i.e. 0,04% of all votes in the meeting. Thus the resolution was adopted.
4. Remuneration of the Supervisory Board member
To pay the Supervisory Board member Aivar Kempi an one-off payment in the amount of EUR 2,400 and starting from 21.06.2025 a monthly fee of EUR 200.
In favour 2,569,152 votes i.e. 99.96% of all votes in the meeting and against 1,012 votes i.e. 0,04% of all votes in the meeting. Thus the resolution was adopted.
The minutes of the general meeting of shareholders are available on Company's web-page, at http://www.trigonproperty.com/.Rando TomingasMember of the Management Board+372 66 79 200info@trigonproperty.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Accenture's Q3 EPS, Revenue Surpass Estimates
Accenture (NYSE:ACN) beats Q3 estimates as GAAP EPS rises to $3.49, driven by strong consulting demand. Revenue climbed 7.5% year-over-year to $17.7 billion, topping consensus by $380 million, while new bookings totaled $19.7 billion, down 6% in U.S. dollars and 7% in local currency. Warning! GuruFocus has detected 4 Warning Sign with ACN. Generative AI engagements accounted for $1.5 billion of that backlog, signaling sustained appetite for digital transformation projects. Accenture returned cash to shareholders with a 15% dividend hike to $1.48 per share and repurchased or redeemed 6 million shares for $1.8 billion. Looking ahead, the company raised its full-year targets: revenue growth of 6%7% in local currency, a modest 0.2% tailwind from foreign-exchange, and operating margin expansion to 15.6%, up 10 basis points on an adjusted basis. Diluted EPS is now expected between $12.77 and $12.89, while free cash flow guidance was lifted to $9.0 billion$9.7 billion. Why it matters: Investors should note Accenture's balanced growth across legacy and AI services, bolstered by robust cash returns and a raised outlook that underscores confidence in demand resilience. That chart shows Wall Street's 12-month ACN targets sitting at an average of $355, about 16% above today's levels, with bullish bulls eyeing as high as $395 and skeptics at $290. Despite the upbeat outlook, Accenture's shares are actually down double-digits year-to-date, weighed by broader tech sell-offs and profit-taking after last winter's rally. The divergence between the low and high cases highlights how much of the upside hinges on AI spending and macro stability. If consulting budgets hold firm, you could see ACN grind toward those $355$395 marks; if belt-tightening returns, it might test sub-$300 territory again. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Accenture's Q3 EPS, Revenue Surpass Estimates
Accenture (NYSE:ACN) beats Q3 estimates as GAAP EPS rises to $3.49, driven by strong consulting demand. Revenue climbed 7.5% year-over-year to $17.7 billion, topping consensus by $380 million, while new bookings totaled $19.7 billion, down 6% in U.S. dollars and 7% in local currency. Warning! GuruFocus has detected 4 Warning Sign with ACN. Generative AI engagements accounted for $1.5 billion of that backlog, signaling sustained appetite for digital transformation projects. Accenture returned cash to shareholders with a 15% dividend hike to $1.48 per share and repurchased or redeemed 6 million shares for $1.8 billion. Looking ahead, the company raised its full-year targets: revenue growth of 6%7% in local currency, a modest 0.2% tailwind from foreign-exchange, and operating margin expansion to 15.6%, up 10 basis points on an adjusted basis. Diluted EPS is now expected between $12.77 and $12.89, while free cash flow guidance was lifted to $9.0 billion$9.7 billion. Why it matters: Investors should note Accenture's balanced growth across legacy and AI services, bolstered by robust cash returns and a raised outlook that underscores confidence in demand resilience. That chart shows Wall Street's 12-month ACN targets sitting at an average of $355, about 16% above today's levels, with bullish bulls eyeing as high as $395 and skeptics at $290. Despite the upbeat outlook, Accenture's shares are actually down double-digits year-to-date, weighed by broader tech sell-offs and profit-taking after last winter's rally. The divergence between the low and high cases highlights how much of the upside hinges on AI spending and macro stability. If consulting budgets hold firm, you could see ACN grind toward those $355$395 marks; if belt-tightening returns, it might test sub-$300 territory again. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
With 59% institutional ownership, eHealth, Inc. (NASDAQ:EHTH) is a favorite amongst the big guns
Institutions' substantial holdings in eHealth implies that they have significant influence over the company's share price The top 17 shareholders own 51% of the company Insiders have been buying lately AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Every investor in eHealth, Inc. (NASDAQ:EHTH) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 59% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Therefore, a good portion of institutional money invested in the company is usually a huge vote of confidence on its future. In the chart below, we zoom in on the different ownership groups of eHealth. Check out our latest analysis for eHealth Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. We can see that eHealth does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of eHealth, (below). Of course, keep in mind that there are other factors to consider, too. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It looks like hedge funds own 14% of eHealth shares. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Our data shows that 8 Knots Management, LLC is the largest shareholder with 8.1% of shares outstanding. For context, the second largest shareholder holds about 5.6% of the shares outstanding, followed by an ownership of 4.4% by the third-largest shareholder. In addition, we found that Francis Soistman, the CEO has 2.3% of the shares allocated to their name. After doing some more digging, we found that the top 17 have the combined ownership of 51% in the company, suggesting that no single shareholder has significant control over the company. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances. We can report that insiders do own shares in eHealth, Inc.. As individuals, the insiders collectively own US$7.4m worth of the US$123m company. It is good to see some investment by insiders, but we usually like to see higher insider holdings. It might be worth checking if those insiders have been buying. With a 21% ownership, the general public, mostly comprising of individual investors, have some degree of sway over eHealth. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. It's always worth thinking about the different groups who own shares in a company. But to understand eHealth better, we need to consider many other factors. Take risks for example - eHealth has 2 warning signs we think you should be aware of. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
